JP2023502387A5 - - Google Patents

Info

Publication number
JP2023502387A5
JP2023502387A5 JP2022528970A JP2022528970A JP2023502387A5 JP 2023502387 A5 JP2023502387 A5 JP 2023502387A5 JP 2022528970 A JP2022528970 A JP 2022528970A JP 2022528970 A JP2022528970 A JP 2022528970A JP 2023502387 A5 JP2023502387 A5 JP 2023502387A5
Authority
JP
Japan
Application number
JP2022528970A
Other languages
Japanese (ja)
Other versions
JPWO2021101739A5 (https=
JP2023502387A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/059604 external-priority patent/WO2021101739A1/en
Publication of JP2023502387A publication Critical patent/JP2023502387A/ja
Publication of JPWO2021101739A5 publication Critical patent/JPWO2021101739A5/ja
Publication of JP2023502387A5 publication Critical patent/JP2023502387A5/ja
Pending legal-status Critical Current

Links

JP2022528970A 2019-11-19 2020-11-09 ジカウイルスを中和するヒト抗体およびその使用方法 Pending JP2023502387A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962937603P 2019-11-19 2019-11-19
US62/937,603 2019-11-19
PCT/US2020/059604 WO2021101739A1 (en) 2019-11-19 2020-11-09 Human antibodies that neutralize zika virus and methods of use therefor

Publications (3)

Publication Number Publication Date
JP2023502387A JP2023502387A (ja) 2023-01-24
JPWO2021101739A5 JPWO2021101739A5 (https=) 2023-11-06
JP2023502387A5 true JP2023502387A5 (https=) 2023-11-06

Family

ID=75980179

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022528970A Pending JP2023502387A (ja) 2019-11-19 2020-11-09 ジカウイルスを中和するヒト抗体およびその使用方法

Country Status (8)

Country Link
US (1) US20230085393A1 (https=)
EP (1) EP4061422A4 (https=)
JP (1) JP2023502387A (https=)
KR (1) KR20220103761A (https=)
CN (1) CN115135345A (https=)
BR (1) BR112022009574A2 (https=)
CA (1) CA3158401A1 (https=)
WO (1) WO2021101739A1 (https=)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9562101B2 (en) * 2013-06-21 2017-02-07 Novartis Ag Lectin-like oxidized LDL receptor 1 antibodies and methods of use
WO2018010789A1 (en) * 2016-07-13 2018-01-18 Humabs Biomed Sa Novel antibodies specifically binding to zika virus epitopes and uses thereof
EP3534953A4 (en) * 2016-11-02 2020-10-07 Vanderbilt University ANTIBODIES AGAINST HUMAN ZIKA VIRUS AND THEIR USE PROCEDURES
US11370830B2 (en) * 2017-04-07 2022-06-28 The Rockefeller University Neutralizing antibodies that bind to the zika virus domain III envelope region

Similar Documents

Publication Publication Date Title
JP2023502387A5 (https=)
CN306296180S (https=)
CN306292821S (https=)
CN305536217S (https=)
CN305535367S (https=)
CN305534549S (https=)
CN305534056S (https=)
CN305533727S (https=)
CN305530619S (https=)
CN305530505S (https=)
CN305530319S (https=)
CN305530288S (https=)
CN305530021S (https=)
CN305529635S (https=)
CN305529131S (https=)
CN305528758S (https=)
CN305528684S (https=)
CN305528401S (https=)
CN305527998S (https=)
CN305527380S (https=)
CN306322299S (https=)
CN306321593S (https=)
CN306320711S (https=)
CN306319238S (https=)
CN306318253S (https=)